Defining the Genetic Basis for the Development of Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the Carney Complex | MicrobiomeTrials← Back to trialsNCT00001452
Defining the Genetic Basis for the Development of Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the Carney Complex
CompletedOBSERVATIONAL
Trial Details
Enrollment target: 1,387 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
HypercortisolismType 2 Diabetes (T2DM)
The goal of this observational study is to explore the prevalence of hypercortisolism in a population with difficult to …
Shanghai, ChinaEst. completion Jun 30, 2027
Endocrine DisordersHypertensionPrimary AldosteronismCortisol ExcessObesity & OverweightHealthy Adult
The goal of this trial is to learn whether wearable devices and hormone sampling can measure how the body changes during…
Zurich, SwitzerlandEst. completion Aug 2031
Adrenal Gland Neoplasm
The adrenal glands, located atop the kidneys, normally produce several types of hormones. Tumors of these glands may or …
Bethesda, United States